Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: J.F. who wrote (21405)	12/22/2006 4:51:28 PM
From: Galirayo	Respond to of 23958

No Preferred just common. Oh well. EPIX too but with preferred and warrants. WASHINGTON, Dec 22 (Reuters) - EPIX Pharmaceuticals Inc. (EPIX.O: Quote, Profile , Research) on Friday said it may periodically sell up to $75 million in common and preferred stock and warrants. The company said it plans to use the proceeds for general corporate purposes, which may include clinical trials, research and development, regulatory activities and product marketing. Under a shelf registration filed with the U.S. Securities and Exchange Commission, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale.

To: J.F. who wrote (21405)	12/22/2006 4:53:06 PM
From: ACAN	Respond to of 23958

jf; [nxxi] settlement with GNC $2,600,000 cash of other income or a 4 cent gain on settlement to NXXI GNC will stock Chromax and a min. purchase of 30,000 bottles for the 07 and 08 calendar year at 9.75 per bottle so gross revenues of $292,500 each year. That is another 4800 store where we will be stocked. GNC will pay us of ingredients sales for the GNC private lable chromium picolinate the amount per kilogram was undisclosed. Also, I didnt know that GNC provided the private label for Rite aid which will now start to be produced by Nutrition 21 on Jan 31, 2007. So this is a win win for us and i dont understand why we arent up higher on this news.